India Alkem Laboratories gains on quarterly profit rise
** Alkem Laboratories ALKE.NS rises 4.5% to 5,064 rupees; marks biggest intraday pct gain since May 6 ** Pharma products maker posts ~22% y/y rise in June-quarter consol net profit; consol rev from ops up 11.2% y/y ** More than 131,357 shares traded, 1.2x the 30-day avg ** Stock rated "hold" on avg; median PT is 5,022.5 rupees, per data compiled by LSEG ** YTD, ALKE down 10% (Reporting by Rudra Pratap Singh in Bengaluru) ((rudrapratap.singh@thomsonreuters.com))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees